Literature DB >> 11139196

Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome.

I S Klasen1, J H Göertz, G A van de Wiel, C M Weemaes, J W van der Meer, J P Drenth.   

Abstract

The hyperimmunoglobulinemia D syndrome (HIDS) is an autosomal recessive disorder characterized by recurrent febrile attacks with abdominal, articular, and skin manifestations. Apart from elevated immunoglobulin D (IgD) levels (>100 IU/ml), there are high IgA levels in the majority of cases. Mutations in the gene encoding mevalonate kinase constitute the molecular defect in HIDS. The cause of elevated IgA concentrations in HIDS patients remains to be elucidated. We studied the hyper-IgA response in serum of a group of HIDS patients. Elevated IgA concentrations result from increased IgA1 concentrations. IgA and IgA1 concentrations correlated significantly with IgD concentrations, and levels of IgA polymers were significantly higher than the levels in healthy donors. These results indicate a continuous, presumably systemic, stimulation of IgA in HIDS patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139196      PMCID: PMC96011          DOI: 10.1128/CDLI.8.1.58-61.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  30 in total

Review 1.  Immunoglobulin D: properties, measurement, and clinical relevance.

Authors:  A O Vladutiu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Recognition of IgD and periodic fever.

Authors:  J P Drenth; I S Klasen; J W van der Meer
Journal:  Ann Intern Med       Date:  1996-09-15       Impact factor: 25.391

3.  The fragmentation of human IgD during storage.

Authors:  F Skvaril; J Rádl
Journal:  Clin Chim Acta       Date:  1967-03       Impact factor: 3.786

4.  Hyperimmunoglobulinaemia D and periodic fever: a new syndrome.

Authors:  J W van der Meer; J M Vossen; J Radl; J A van Nieuwkoop; C J Meyer; S Lobatto; R van Furth
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

5.  Identification and measurement of paraprotein polymers by high performance gel filtration chromatography.

Authors:  E H Cooper; R Turner; E A Johns; R A Crockson
Journal:  Biomed Pharmacother       Date:  1985       Impact factor: 6.529

6.  High proportion of polymeric IgA in young infants' sera and independence between IgA-size and IgA-subclass distributions.

Authors:  D L Delacroix; E Liroux; J P Vaerman
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

7.  Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome.

Authors:  S M Houten; W Kuis; M Duran; T J de Koning; A van Royen-Kerkhof; G J Romeijn; J Frenkel; L Dorland; M M de Barse; W A Huijbers; G T Rijkers; H R Waterham; R J Wanders; B T Poll-The
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

8.  Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver disease.

Authors:  M M Newkirk; M H Klein; A Katz; M M Fisher; B J Underdown
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

9.  Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy.

Authors:  R M Valentijn; J Radl; J J Haaijman; B J Vermeer; J J Weening; R H Kauffmann; M R Daha; L A van Es
Journal:  Kidney Int       Date:  1984-11       Impact factor: 10.612

10.  Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A.

Authors:  D L Delacroix; K B Elkom; A P Geubel; H F Hodgson; C Dive; J P Vaerman
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

View more
  9 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

2.  Hyperimmunoglobulinaemia D syndrome in India: report of two siblings with a novel mutation.

Authors:  A Lawrence; F Hol; A Aggarwal; J P H Drenth
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

3.  A rare cause of steroid-resistant nephrotic syndrome in a child: Answers.

Authors:  Lale Guliyeva; Yılmaz Tabel; Ali Düzova; Nusret Akpolat; Seza Özen; Rezan Topaloğlu; Betül Sözeri
Journal:  Pediatr Nephrol       Date:  2019-12-06       Impact factor: 3.714

4.  An Atypical Presentation of Mevalonate Kinase Deficiency in Response to Colchicine Treatment.

Authors:  Merve Koç Yekedüz; Neslihan Doğulu; Ümmühan Öncül; Engin Köse; Serdar Ceylaner; Fatma Tuba Eminoğlu
Journal:  Mol Syndromol       Date:  2021-10-25

5.  Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome.

Authors:  E J Hager; H M Tse; J D Piganelli; M Gupta; M Baetscher; T E Tse; A S Pappu; R D Steiner; G F Hoffmann; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2007-11-19       Impact factor: 4.982

Review 6.  Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome.

Authors:  Dorothea Haas; Georg F Hoffmann
Journal:  Orphanet J Rare Dis       Date:  2006-04-26       Impact factor: 4.123

7.  Association of KCTD10, MVK, and MMAB polymorphisms with dyslipidemia and coronary heart disease in Han Chinese population.

Authors:  Jie Sun; Yun Qian; Yue Jiang; Jiaping Chen; Juncheng Dai; Guangfu Jin; Jianming Wang; Zhibin Hu; Sijun Liu; Chong Shen; Hongbing Shen
Journal:  Lipids Health Dis       Date:  2016-10-04       Impact factor: 3.876

8.  Epigenetic Modulation of Class-Switch DNA Recombination to IgA by miR-146a Through Downregulation of Smad2, Smad3 and Smad4.

Authors:  Paolo Casali; Shili Li; Grecia Morales; Cassidy C Daw; Daniel P Chupp; Amanda D Fisher; Hong Zan
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

9.  Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome.

Authors:  Jacob F de Wolff; Stephen J Dickinson; Alice C Smith; Karen Molyneux; John Feehally; Anna Simon; Jonathan Barratt
Journal:  Clin Exp Med       Date:  2009-06-20       Impact factor: 3.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.